Increased Urinary Exosomal MicroRNAs in Patients with Systemic Lupus Erythematosus

There is increased interest in using microRNAs (miRNAs) as biomarkers in different diseases. Present in body fluids, it is controversial whether or not they are mainly enclosed in exosomes, thus we studied if urinary miRNAs are concentrated inside exosomes and if the presence of systemic lupus erythematosus with or without lupus nephritis modifies their distribution pattern. We quantified specific miRNAs in urine of patients with systemic lupus erythematosus (n = 38) and healthy controls (n = 12) by quantitative reverse-transcription PCR in cell-free urine, exosome-depleted supernatant and exosome pellet obtained by ultracentrifugation. In control group, miR-335* and miR-302d were consistently higher in exosomes than in exosome-depleted supernatant, and miR-200c and miR-146a were higher in cell-free fraction. In lupus patients, all urinary miRNAs tested were mainly in exosomes with lower levels outside them (p<0.05 and p<0.01, respectively). This pattern is especially relevant in patients with active lupus nephritis compared to the control group or to the SLE patients in absence of lupus nephritis, with miR-146a being the most augmented (100-fold change, p<0.001). Among the exosomal miRNAs tested, only the miR-146a discriminates the presence of active lupus nephritis. In conclusion, urinary miRNAs are contained primarily in exosomes in systemic lupus erythematosus, and the main increment was found in the presence of active lupus nephritis. These findings underscore the attractiveness of exosomal miRNAs in urine, a non-invasive method, as potential renal disease markers.

[1]  Lesley Cheng,et al.  Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. , 2014, Kidney International.

[2]  Andrew F. Hill,et al.  Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles , 2014, Journal of extracellular vesicles.

[3]  F. Sánchez‐Madrid,et al.  Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs , 2013, Nature Communications.

[4]  S. Waikar,et al.  Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury. , 2013, Clinical chemistry.

[5]  D. Cimino,et al.  Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy , 2013, PloS one.

[6]  K. Ma,et al.  Isolation and Quantification of MicroRNAs from Urinary Exosomes/Microvesicles for Biomarker Discovery , 2013, International journal of biological sciences.

[7]  X. Chen,et al.  Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. , 2013, Clinical chemistry.

[8]  J. Gleadle,et al.  Exosomes and the kidney: Blaming the messenger , 2013, Nephrology.

[9]  D. Brazil,et al.  CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGF&bgr; type II receptor with implications for nephropathic cell phenotypes , 2012, Journal of Cell Science.

[10]  Mahdieh Khosroheidari,et al.  Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. , 2012, Kidney international.

[11]  A. Hill,et al.  Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells , 2012, Nucleic acids research.

[12]  Wu-xian Li,et al.  Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. , 2012, Translational research : the journal of laboratory and clinical medicine.

[13]  F. Hamdy,et al.  An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer , 2012, British Journal of Cancer.

[14]  Jai Radhakrishnan,et al.  Notice , 2012, Kidney International Supplements.

[15]  Jianxin Lu,et al.  Glomerular and tubulointerstitial miR‐638, miR‐198 and miR‐146a expression in lupus nephritis , 2012, Nephrology.

[16]  K. Vickers,et al.  Lipid-based carriers of microRNAs and intercellular communication , 2012, Current opinion in lipidology.

[17]  J. Bertram,et al.  Role of microRNAs in kidney homeostasis and disease. , 2012, Kidney international.

[18]  G. Illei,et al.  The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes , 2012, PloS one.

[19]  B. W. van Balkom,et al.  Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases , 2011, Kidney International.

[20]  M. Michael,et al.  Circulating microRNA expression is reduced in chronic kidney disease. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  D. Fliser,et al.  Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[22]  P. Altevogt,et al.  Body fluid derived exosomes as a novel template for clinical diagnostics , 2011, Journal of Translational Medicine.

[23]  H. Haller,et al.  MicroRNAs as mediators and therapeutic targets in chronic kidney disease , 2011, Nature Reviews Nephrology.

[24]  E. Kroh,et al.  Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.

[25]  E. Li,et al.  Serum and urinary free microRNA level in patients with systemic lupus erythematosus , 2011, Lupus.

[26]  J. Lötvall,et al.  Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages , 2011, Journal of Translational Medicine.

[27]  Jessica A. Weber,et al.  The microRNA spectrum in 12 body fluids. , 2010, Clinical chemistry.

[28]  M. Mayr,et al.  Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes , 2010, Circulation research.

[29]  S. Mathivanan,et al.  Exosomes: extracellular organelles important in intercellular communication. , 2010, Journal of proteomics.

[30]  G. Illei,et al.  MicroRNAs as biomarkers in rheumatic diseases , 2010, Nature Reviews Rheumatology.

[31]  Igor M. Dozmorov,et al.  Identification of Unique MicroRNA Signature Associated with Lupus Nephritis , 2010, PloS one.

[32]  Gang Wang,et al.  Expression of MicroRNAs in the Urinary Sediment of Patients with IgA Nephropathy , 2010, Disease markers.

[33]  M. Hristov,et al.  Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection , 2009, Science Signaling.

[34]  X. Chen.  MicroRNA signatures in liver diseases. , 2009, World journal of gastroenterology.

[35]  P. Tak,et al.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.

[36]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[37]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[38]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[39]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[40]  R. Plasterk,et al.  The diverse functions of microRNAs in animal development and disease. , 2006, Developmental cell.

[41]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[42]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[43]  A. Blank,et al.  Multiple ribonucleases of human urine. , 1981, Biochemistry.